The future of the global endoluminal suturing device market looks promising with opportunities in the hospital, clinic, and ambulatory surgical center markets. The global endoluminal suturing device market is expected to reach an estimated $0.16 billion by 2030 with a CAGR of 11.5% from 2024 to 2030. The major drivers for this market are growing number of gastrointestinal cancers, increasing preference for minimally invasive weight loss surgeries, and rising incidence of obesity.
Some of the key questions
answered in this exclusive report are:
Q.1. What are some of
the most promising, high-growth opportunities for the endoluminal suturing
device market by application (bariatric surgery, gastrointestinal surgery,
gastroesophageal reflux disease surgery, and others), end use (hospitals,
clinics, ambulatory surgical centers, and others), and region (North America,
Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will
grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and
why?
Q.4. What are the key
factors affecting market dynamics? What are the key challenges and business
risks in this market?
Q.5. What are the
business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market
and the reasons behind them?
Q.7. What are some of
the changing demands of customers in the market?
Q.8. What are the new
developments in the market? Which companies are leading these developments?
Q.9. Who are the major
players in this market? What strategic initiatives are key players pursuing for
business growth?
Q.10. What are some of
the competing products in this market and how big of a threat do they pose for
loss of market share by material or product substitution?
Q.11. What M&A
activity has occurred in the last 5 years and what has its impact been on the
industry?
Market Segmentation:
In this market,
bariatric surgery, gastrointestinal surgery, and gastroesophageal reflux
disease surgery are the major segments of endoluminal suturing device market by
application. Lucintel forecasts that gastrointestinal surgery will remain the
largest segment due to its growing usage in the treatment of gastrointestinal
cancers and gastrointestinal disorders. Within this market, hospital will
remain the largest segment due to rising demand for endoluminal suturing
devices in this setting by skilled healthcare professionals for the treatment
of patients undergoing bariatric procedures or chronic diseases.
North America will
remain the largest region due to existenc of well-established healthcare
system, growing volume of surgical operations, and presence of key players in
the region.
Apollo Endosurgery,
Johnson & Johnson, Medtronic, Cook, USGI Medical, Ovesco Endoscopy, Endo
Tools Therapeutics, Ergosuture, and Sutrue are the major suppliers in the endoluminal
suturing device market.
About
Lucintel
Lucintel, the premier global
management consulting and market research firm, creates winning strategies for
growth. It offers market assessments, competitive analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Related reports
1. Pharmaceutical Contract Manufacturing Market
3. Stent Market
4. Wheelchair Market :
5. 3D
Printing Medical Device Market:
8. Medical Lifting Sling
Market:
10. Stretcher Market:
No comments:
Post a Comment